Pacific Biosciences discloses CCO Jeff Eidel's separation terms: $485K severance, 12-month COBRA

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Jeff Eidel's employment as CCO ended Nov 15, 2024; separation agreement signed Dec 6, effective Dec 13.
Eidel receives lump sum of $485,000 (12 months base salary) and up to 12 months COBRA premium payments.
Vested stock options must be exercised within 3 months of separation or forfeited; unvested RSUs/PSUs cancelled.
Eidel agrees to release all claims, maintain confidentiality, and refrain from disparagement.
Company will instruct executive officers and board to refrain from disparaging Eidel.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.